Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Exosome Diagnostic and Therapeutic Market by Type (Instrument, Reagent, Software), By Application (Cancer Institute, Hospital, Diagnostic Center, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Exosome Diagnostic and Therapeutic Market by Type (Instrument, Reagent, Software), By Application (Cancer Institute, Hospital, Diagnostic Center, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 137778 3300 Medical Devices & Consumables 377 237 Pages 4.6 (45)

Market Overview:

The global exosome diagnostic and therapeutic market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing incidence of cancer, rising demand for personalized medicine, and technological advancements in exosome diagnostics. The global exosome diagnostic and therapeutic market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into instruments, reagents, and software. The instruments segment is further sub-segmented into extraction kits/devices/systems and analysis systems. The reagents segment is further sub-segmented into antibodies/proteins/enzymes and nucleic acids (DNA or RNA). The software segment includes data management tools for analyzing exosomes as well as downstream data analysis tools used for biomarker identification from exosomes. On the basis of application, the market is divided into cancer institutes, hospitals & clinics (including pathology labs), diagnostic centers (including reference labs), research institutes & universities; biotechnology & pharmaceutical companies; contract research organizations (CROs); other end users such as nutraceutical companies etc.).

Global Exosome Diagnostic and Therapeutic Industry Outlook

Product Definition:

Exosomes are small vesicles released by cells that can mediate cell-to-cell communication and carry cargo such as proteins, lipids and nucleic acids. Exosomes have been proposed as a new class of biomarkers for cancer diagnosis and prognosis, and also present potential therapeutic targets.


Instruments are devices or machines that help in collecting, analyzing and presenting data for research purpose. It can be broadly segmented into two categories, one is analytical and other is therapeutic. Analytical segment includes instruments used for measuring specific properties of molecules such as size, shape and chemical composition while therapeutic category consists of devices used for treatment or therapy.


Reagents are chemicals that help in enhancing or detecting a specific property of a biological specimen. In the case of molecular biology, reagents are used to detect and purify DNA, RNA, Proteins etc. The most commonly used reagent is PCR (polymerase chain reaction) which helps in amplifying a specific region from an initial sample to exponential levels for further analysis.

Application Insights:

The cancer institute segment dominated the global exosome diagnostic and therapeutic market in 2017. This can be attributed to factors such as increasing government funding for cancer research, growing awareness about advanced treatment options, and rising prevalence of the disease. For instance, according to the American Cancer Society there were an estimated 210,480 new cases of invasive breast carcinoma diagnosed in women across the globe in 2018. Therefore, demand for early diagnosis is expected to increase over time which will drive growth during forecast period.

On other hand, hospital-based diagnostics are anticipated to witness lucrative growth during forecast period owing to factors such as increasing number of patients with chronic diseases like Parkinson¢â‚¬â„¢s disease or multiple sclerosis who require long term care & higher reimbursement rates by insurance companies for these diseases coupled with technological advancements that enhance accuracy of tests performed at hospitals & healthcare centers.

Regional Analysis:

North America dominated the global market in 2017. This can be attributed to the presence of a large number of key players, increasing prevalence of cancer, and availability of reimbursement facilities for diagnostic procedures. The U.S.-based companies are engaged in extensive research activities to develop novel reagents and assays for use across different disease areas including oncology and infectious diseases such as HIV/AIDS, malaria & dengue fever etc.

Asia Pacific is expected to witness lucrative growth over the forecast period owing to factors such as rapidly improving healthcare infrastructure with an increase in government spending on medical research coupled with rising awareness about early diagnosis leading towards higher adoption rates for exosome-based diagnostics & therapeutics among patients throughout this region will drive growth over next eight years.

Growth Factors:

  • Increasing demand for personalized medicine
  • Rising prevalence of chronic diseases
  • Technological advancements in exosome isolation and analysis techniques
  • Growing investment in research and development of exosome-based diagnostics and therapeutics
  • increasing number of collaborations and partnerships between pharmaceutical companies, biotechnology firms, and academic institutions

Scope Of The Report

Report Attributes

Report Details

Report Title

Exosome Diagnostic and Therapeutic Market Research Report

By Type

Instrument, Reagent, Software

By Application

Cancer Institute, Hospital, Diagnostic Center, Others

By Companies

AMS Biotechnology, ReNeuron, ExoCyte Therapeutics, Cell Guidance Systems, BioRegenerative Sciences, Norgen Biotek, ...

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year


Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year


Number of Pages


Number of Tables & Figures


Customization Available

Yes, the report can be customized as per your need.

Global Exosome Diagnostic and Therapeutic Market Report Segments:

The global Exosome Diagnostic and Therapeutic market is segmented on the basis of:


Instrument, Reagent, Software

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.


Cancer Institute, Hospital, Diagnostic Center, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. AMS Biotechnology
  2. ReNeuron
  3. ExoCyte Therapeutics
  4. Cell Guidance Systems
  5. BioRegenerative Sciences
  6. Norgen Biotek
  7. ...

Global Exosome Diagnostic and Therapeutic Market Overview

Highlights of The Exosome Diagnostic and Therapeutic Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Instrument
    2. Reagent
    3. Software
  1. By Application:

    1. Cancer Institute
    2. Hospital
    3. Diagnostic Center
    4. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Exosome Diagnostic and Therapeutic Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Exosome Diagnostic and Therapeutic Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?

Exosomes are small vesicles that are released by cells and play an important role in cell-to-cell communication. They can be used to diagnose and treat diseases.

Some of the key players operating in the exosome diagnostic and therapeutic market are AMS Biotechnology, ReNeuron, ExoCyte Therapeutics, Cell Guidance Systems, BioRegenerative Sciences, Norgen Biotek.

1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Exosome Diagnostic and Therapeutic Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Exosome Diagnostic and Therapeutic Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Exosome Diagnostic and Therapeutic Market - Supply Chain
   4.5. Global Exosome Diagnostic and Therapeutic Market Forecast
      4.5.1. Exosome Diagnostic and Therapeutic Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Exosome Diagnostic and Therapeutic Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Exosome Diagnostic and Therapeutic Market Absolute $ Opportunity

5. Global Exosome Diagnostic and Therapeutic Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Type
      5.3.1. Instrument
      5.3.2. Reagent
      5.3.3. Software
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Exosome Diagnostic and Therapeutic Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Application
      6.3.1. Cancer Institute
      6.3.2. Hospital
      6.3.3. Diagnostic Center
      6.3.4. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Exosome Diagnostic and Therapeutic Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Exosome Diagnostic and Therapeutic Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Exosome Diagnostic and Therapeutic Demand Share Forecast, 2019-2029

9. North America Exosome Diagnostic and Therapeutic Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Application
      9.4.1. Cancer Institute
      9.4.2. Hospital
      9.4.3. Diagnostic Center
      9.4.4. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Type
      9.7.1. Instrument
      9.7.2. Reagent
      9.7.3. Software
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Exosome Diagnostic and Therapeutic Demand Share Forecast, 2019-2029

10. Latin America Exosome Diagnostic and Therapeutic Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Application
      10.4.1. Cancer Institute
      10.4.2. Hospital
      10.4.3. Diagnostic Center
      10.4.4. Others
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Type
      10.7.1. Instrument
      10.7.2. Reagent
      10.7.3. Software
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Exosome Diagnostic and Therapeutic Demand Share Forecast, 2019-2029

11. Europe Exosome Diagnostic and Therapeutic Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Application
      11.4.1. Cancer Institute
      11.4.2. Hospital
      11.4.3. Diagnostic Center
      11.4.4. Others
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Type
      11.7.1. Instrument
      11.7.2. Reagent
      11.7.3. Software
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Exosome Diagnostic and Therapeutic Demand Share, 2019-2029

12. Asia Pacific Exosome Diagnostic and Therapeutic Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Application
      12.4.1. Cancer Institute
      12.4.2. Hospital
      12.4.3. Diagnostic Center
      12.4.4. Others
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Type
      12.7.1. Instrument
      12.7.2. Reagent
      12.7.3. Software
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Exosome Diagnostic and Therapeutic Demand Share, 2019-2029

13. Middle East & Africa Exosome Diagnostic and Therapeutic Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Application
      13.4.1. Cancer Institute
      13.4.2. Hospital
      13.4.3. Diagnostic Center
      13.4.4. Others
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Type
      13.7.1. Instrument
      13.7.2. Reagent
      13.7.3. Software
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Exosome Diagnostic and Therapeutic Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Exosome Diagnostic and Therapeutic Market: Market Share Analysis
   14.2. Exosome Diagnostic and Therapeutic Distributors and Customers
   14.3. Exosome Diagnostic and Therapeutic Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. AMS Biotechnology Overview Financials Developments Strategic Outlook
      14.4.2. ReNeuron Overview Financials Developments Strategic Outlook
      14.4.3. ExoCyte Therapeutics Overview Financials Developments Strategic Outlook
      14.4.4. Cell Guidance Systems Overview Financials Developments Strategic Outlook
      14.4.5. BioRegenerative Sciences Overview Financials Developments Strategic Outlook
      14.4.6. Norgen Biotek Overview Financials Developments Strategic Outlook
      14.4.7. ... Overview Financials Developments Strategic Outlook
      14.4.8. COMPANY8 Overview Financials Developments Strategic Outlook
      14.4.9. COMPANY9 Overview Financials Developments Strategic Outlook
      14.4.10. COMPANY 10 Overview Financials Developments Strategic Outlook
      14.4.11. COMPANY 11 Overview Financials Developments Strategic Outlook
      14.4.12. COMPANY 12 Overview Financials Developments Strategic Outlook
      14.4.13. COMPANY 13 Overview Financials Developments Strategic Outlook
      14.4.14. COMPANY 14 Overview Financials Developments Strategic Outlook
      14.4.15. COMPANY 15 Overview Financials Developments Strategic Outlook
      14.4.16. COMPANY 16 Overview Financials Developments Strategic Outlook
      14.4.17. COMPANY 17 Overview Financials Developments Strategic Outlook
      14.4.18. COMPANY 18 Overview Financials Developments Strategic Outlook
      14.4.19. COMPANY 19 Overview Financials Developments Strategic Outlook
      14.4.20. COMPANY 20 Overview Financials Developments Strategic Outlook

Our Trusted Clients

Contact Us